Whitepaper: Effective Technology Transfers for Mammalian-Derived Biologics

[Article Title]

The complex set of activities involved in technical transfers of pharmaceutical innovations from research laboratories to clinical and commercial manufacturing is one of the most critical, yet challenging, steps in the drug development process. If product and process knowledge is not exchanged correctly and efficiently, it could result in delays and failures that significantly impact the overall success of the product. Therefore, an effective strategy is essential for facilitating these transfers, as this will help accelerate the translation of projects from bench to market.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.